2021
DOI: 10.1016/j.jri.2021.103361
|View full text |Cite
|
Sign up to set email alerts
|

Tryptophan metabolism and immune regulation in the human placenta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
27
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(32 citation statements)
references
References 120 publications
3
27
0
1
Order By: Relevance
“…As mentioned previously, tryptophan is an essential amino acid that is involved in maintaining the immune privilege of the placenta 116 through the kynurenine pathway that is catalyzed by IDO. 117 After pregnancy, IDO-mediated tryptophan degradation in decidual and peripheral leukocytes was activated coupled with elevated kynurenine. 118 Further analysis showed that IFNγ or cytotoxic T lymphocyte antigen-4 stimulation could increase the expression of IDO in dMφ.…”
Section: Amino Acid Metabolismmentioning
confidence: 99%
“…As mentioned previously, tryptophan is an essential amino acid that is involved in maintaining the immune privilege of the placenta 116 through the kynurenine pathway that is catalyzed by IDO. 117 After pregnancy, IDO-mediated tryptophan degradation in decidual and peripheral leukocytes was activated coupled with elevated kynurenine. 118 Further analysis showed that IFNγ or cytotoxic T lymphocyte antigen-4 stimulation could increase the expression of IDO in dMφ.…”
Section: Amino Acid Metabolismmentioning
confidence: 99%
“…performed a pioneering experiment showing that elevated IDO (namely, IDO1) expression at the maternal–fetal interface was crucial to prevent immune rejection of fetal allografts ( 11 ). Subsequently, extensive studies have demonstrated the immunological regulation role for IDO1 in physiological and pathological states including pregnancy, obesity, transplantation, infectious diseases, autoimmune diseases, neurological diseases, and neoplastic diseases ( 69 72 ). In clinical researches, the expression of IDO1 has been found in various tumors such as breast cancer, melanoma, and bladder cancer, which inactivates surrounding immune cells in TME primarily through abnormalities of Trp metabolism ( 54 , 73 , 74 ).…”
Section: Indoleamine 23-dioxygenase 1 In Modulating the Immunosuppressive Tumor Microenvironmentmentioning
confidence: 99%
“…In addition to its role in protein synthesis, L-Trp is a precursor for two important metabolic pathways, the kynurenine pathway (KP), and the serotonin pathway ( Richard et al, 2009 ; Barik, 2020 ). Physiologically, L-Trp and its metabolites are key regulators of energy production, cellular redox state, neuronal and vascular function, wound healing, as well as innate and adaptive immunity ( Richard et al, 2009 ; Serbecic et al, 2009 ; Li et al, 2012 ; Boccuto et al, 2013 ; Barik, 2020 ; Costantini et al, 2020 ; Fiore and Murray, 2021 ; Haq et al, 2021 ; Silvano et al, 2021 ). Importantly, induction of L-Trp metabolic pathways not only facilitates immunological tolerance and maintenance of immune privilege in the eyes, brain, and placenta, but also modulates pathogen replication through regulation of L-Trp bioavailability ( Serbecic et al, 2009 ; Li et al, 2012 ; Costantini et al, 2020 ; Fiore and Murray, 2021 ; Silvano et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Physiologically, L-Trp and its metabolites are key regulators of energy production, cellular redox state, neuronal and vascular function, wound healing, as well as innate and adaptive immunity ( Richard et al, 2009 ; Serbecic et al, 2009 ; Li et al, 2012 ; Boccuto et al, 2013 ; Barik, 2020 ; Costantini et al, 2020 ; Fiore and Murray, 2021 ; Haq et al, 2021 ; Silvano et al, 2021 ). Importantly, induction of L-Trp metabolic pathways not only facilitates immunological tolerance and maintenance of immune privilege in the eyes, brain, and placenta, but also modulates pathogen replication through regulation of L-Trp bioavailability ( Serbecic et al, 2009 ; Li et al, 2012 ; Costantini et al, 2020 ; Fiore and Murray, 2021 ; Silvano et al, 2021 ). Indeed, one mechanism by which interferon gamma (IFN-g) suppresses pathogen replication, including Chlamydia, Hepatitis B virus, and Parainfluenza virus, is by depleting L-Trp through activation of indoleamine-pyrrole 2,3-dioxygenase (IDO) and the initial KP rate-limiting enzyme ( Carlin et al, 1989 ; Lepiller et al, 2015 ; Rabbani et al, 2016 ; Yoshio et al, 2016 ; Raniga and Liang, 2018 ).…”
Section: Introductionmentioning
confidence: 99%